UniProt ID | FOXJ2_HUMAN | |
---|---|---|
UniProt AC | Q9P0K8 | |
Protein Name | Forkhead box protein J2 | |
Gene Name | FOXJ2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 574 | |
Subcellular Localization | Nucleus. | |
Protein Description | Transcriptional activator. Able to bind to two different type of DNA binding sites. Isoform FOXJ2.L behaves as a more potent transactivator than FOXJ2.S.. | |
Protein Sequence | MASDLESSLTSIDWLPQLTLRATIEKLGSASQAGPPGSSRKCSPGSPTDPNATLSKDEAAVHQDGKPRYSYATLITYAINSSPAKKMTLSEIYRWICDNFPYYKNAGIGWKNSIRHNLSLNKCFRKVPRPRDDPGKGSYWTIDTCPDISRKRRHPPDDDLSQDSPEQEASKSPRGGVAGSGEASLPPEGNPQMSLQSPTSIASYSQGTGSVDGGAVAAGASGRESAEGPPPLYNTNHDFKFSYSEINFQDLSWSFRNLYKSMLEKSSSSSQHGFSSLLGDIPPSNNYYMYQQQQPPPPQQQQQQQQPPQPPPQQSQPQQQQAPAQGPSAVGGAPPLHTPSTDGCTPPGGKQAGAEGYGPPPVMAMHPPPLQHGGYHPHQHHPHSHPAQQPPPPQPQAQGQAPINNTGFAFPSDWCSNIDSLKESFKMVNRLNWSSIEQSQFSELMESLRQAEQKNWTLDQHHIANLCDSLNHFLTQTGHVPPQGGTHRPPAPARIADSCALTSGKQESAMSQVNSYGHPQAPHLYPGPSPMYPIPTQDSAGYNRPAHHMVPRPSVPPPGANEEIPDDFDWDLIT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MASDLESSL ------CCCHHHHHC | 16.26 | 20068231 | |
3 | Phosphorylation | -----MASDLESSLT -----CCCHHHHHCH | 41.24 | 25159151 | |
7 | Phosphorylation | -MASDLESSLTSIDW -CCCHHHHHCHHHHH | 37.63 | 30108239 | |
8 | Phosphorylation | MASDLESSLTSIDWL CCCHHHHHCHHHHHH | 26.70 | 30108239 | |
10 | Phosphorylation | SDLESSLTSIDWLPQ CHHHHHCHHHHHHHH | 26.11 | 30108239 | |
11 | Phosphorylation | DLESSLTSIDWLPQL HHHHHCHHHHHHHHH | 24.68 | 28464451 | |
23 | Phosphorylation | PQLTLRATIEKLGSA HHHHHHHHHHHHHCH | 24.20 | 20068231 | |
26 | Ubiquitination | TLRATIEKLGSASQA HHHHHHHHHHCHHHC | 55.06 | 29967540 | |
29 | Phosphorylation | ATIEKLGSASQAGPP HHHHHHHCHHHCCCC | 34.87 | 20068231 | |
31 | Phosphorylation | IEKLGSASQAGPPGS HHHHHCHHHCCCCCC | 23.43 | 20068231 | |
38 | Phosphorylation | SQAGPPGSSRKCSPG HHCCCCCCCCCCCCC | 32.51 | 25159151 | |
39 | Phosphorylation | QAGPPGSSRKCSPGS HCCCCCCCCCCCCCC | 41.49 | 26074081 | |
43 | Phosphorylation | PGSSRKCSPGSPTDP CCCCCCCCCCCCCCC | 35.02 | 23927012 | |
46 | Phosphorylation | SRKCSPGSPTDPNAT CCCCCCCCCCCCCCC | 28.19 | 29255136 | |
48 | Phosphorylation | KCSPGSPTDPNATLS CCCCCCCCCCCCCCC | 66.83 | 29255136 | |
53 | Phosphorylation | SPTDPNATLSKDEAA CCCCCCCCCCHHHHH | 37.90 | 20068231 | |
55 | Phosphorylation | TDPNATLSKDEAAVH CCCCCCCCHHHHHHC | 33.43 | 28464451 | |
69 | Phosphorylation | HQDGKPRYSYATLIT CCCCCCCCEEEHHHH | 17.98 | 26074081 | |
70 | Phosphorylation | QDGKPRYSYATLITY CCCCCCCEEEHHHHH | 15.01 | 26074081 | |
71 | Phosphorylation | DGKPRYSYATLITYA CCCCCCEEEHHHHHH | 8.48 | 26074081 | |
73 | Phosphorylation | KPRYSYATLITYAIN CCCCEEEHHHHHHHH | 15.51 | 26074081 | |
76 | Phosphorylation | YSYATLITYAINSSP CEEEHHHHHHHHCCH | 15.26 | 26074081 | |
77 | Phosphorylation | SYATLITYAINSSPA EEEHHHHHHHHCCHH | 9.86 | 26074081 | |
81 | Phosphorylation | LITYAINSSPAKKMT HHHHHHHCCHHHCCC | 31.42 | 26074081 | |
82 | Phosphorylation | ITYAINSSPAKKMTL HHHHHHCCHHHCCCH | 25.12 | 26074081 | |
111 | Ubiquitination | KNAGIGWKNSIRHNL HCCCCCHHHHHHHHC | 35.29 | 29967540 | |
119 | Phosphorylation | NSIRHNLSLNKCFRK HHHHHHCHHHHHCCC | 34.90 | 21712546 | |
122 | Ubiquitination | RHNLSLNKCFRKVPR HHHCHHHHHCCCCCC | 39.79 | 29967540 | |
136 | Ubiquitination | RPRDDPGKGSYWTID CCCCCCCCCCEEECC | 50.50 | 29967540 | |
138 | Phosphorylation | RDDPGKGSYWTIDTC CCCCCCCCEEECCCC | 22.45 | 20068231 | |
149 | Phosphorylation | IDTCPDISRKRRHPP CCCCCCHHHCCCCCC | 38.85 | 20068231 | |
161 | Phosphorylation | HPPDDDLSQDSPEQE CCCCCCCCCCCHHHH | 38.65 | 17525332 | |
164 | Phosphorylation | DDDLSQDSPEQEASK CCCCCCCCHHHHHHH | 23.77 | 25159151 | |
170 | Phosphorylation | DSPEQEASKSPRGGV CCHHHHHHHCCCCCC | 32.68 | 23401153 | |
172 | Phosphorylation | PEQEASKSPRGGVAG HHHHHHHCCCCCCCC | 19.82 | 23401153 | |
197 | Phosphorylation | NPQMSLQSPTSIASY CCCCCCCCCCCCCCC | 35.12 | 12787665 | |
225 | Phosphorylation | AGASGRESAEGPPPL CCCCCCCCCCCCCCC | 30.20 | 28985074 | |
252 | Phosphorylation | EINFQDLSWSFRNLY ECCHHHHHHHHHHHH | 29.03 | 27251275 | |
254 | Phosphorylation | NFQDLSWSFRNLYKS CHHHHHHHHHHHHHH | 15.79 | 27251275 | |
259 | Phosphorylation | SWSFRNLYKSMLEKS HHHHHHHHHHHHHHC | 12.45 | 18669648 | |
260 | Ubiquitination | WSFRNLYKSMLEKSS HHHHHHHHHHHHHCC | 32.33 | - | |
261 | Phosphorylation | SFRNLYKSMLEKSSS HHHHHHHHHHHHCCC | 18.29 | 18669648 | |
434 | Phosphorylation | MVNRLNWSSIEQSQF HHHCCCHHHHCHHHH | 21.99 | 23090842 | |
435 | Phosphorylation | VNRLNWSSIEQSQFS HHCCCHHHHCHHHHH | 23.04 | 28450419 | |
439 | Phosphorylation | NWSSIEQSQFSELME CHHHHCHHHHHHHHH | 22.02 | 23090842 | |
447 | Phosphorylation | QFSELMESLRQAEQK HHHHHHHHHHHHHHH | 18.19 | 22673903 | |
498 | Phosphorylation | APARIADSCALTSGK CCCCHHHHCCCCCCC | 7.71 | 24719451 | |
503 | Phosphorylation | ADSCALTSGKQESAM HHHCCCCCCCHHHHH | 44.86 | 24719451 | |
508 (in isoform 2) | Phosphorylation | - | 27.12 | 24043423 | |
511 (in isoform 2) | Phosphorylation | - | 30.60 | 24043423 | |
514 (in isoform 2) | Phosphorylation | - | 23.13 | 24043423 | |
517 (in isoform 2) | Phosphorylation | - | 26.31 | 24043423 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FOXJ2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FOXJ2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FOXJ2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-172, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-259 AND SER-261, ANDMASS SPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-161, AND MASSSPECTROMETRY. |